Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 13,332 shares at $18.71 ($249K) on 2011-05-19, disclosed to the SEC on 2011-05-20.
Scheduled sale ($249k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.70 | 5,413 | $101K | 40.6% |
| 2 | $18.71 | 1,253 | $23K | 9.4% |
| 3 | $18.71 | 6,666 | $125K | 50.0% |
| Total | $18.71 avg | 13,332 | $249K | 100% |
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |